top of page
Abstract Blue Circles
Antibody_IgG1_surface.png
Antibody_IgG1_surface.png
ChatGPT Image Mar 26, 2026, 09_18_35 AM.png
612f6965a87d6f28468b4571-removebg-preview.png
612f6965a87d6f28468b4571-removebg-preview.png

NeuroShielD

Predicting & Preventing Viral Brain Entry

612f6965a87d6f28468b4571-removebg-preview.png
612f6965a87d6f28468b4571-removebg-preview.png
Antibody_IgG1_surface.png
Antibody_IgG1_surface.png
image_edited.png
1_k8dxBOGGLQ0Jx-VeVWcxsg_edited_edited.p

The Problem

Viral infections affect hundreds of millions of people each year, and studies show that up to 30–50% of patients in certain outbreaks experience neurological symptoms. Despite this risk, most treatments act after infection has progressed and do not address early mechanisms of brain entry.

1_k8dxBOGGLQ0Jx-VeVWcxsg_edited_edited.p
image_edited.png


Our Solution

NeuroShield is a predictive system in which a biosurveillance scanner collects biological signals that are analyzed by an AI-driven algorithm to generate a Neuroinvasion Risk Index (NRI). Identifying elevated risk levels enables targeted responses using nanocarrier-based delivery to act at the blood-brain barrier before viral entry occurs.

image.png


IMPACT

By targeting early stages of neuroinvasion, NeuroShield has the potential to reduce neurological complications in a significant portion of cases. Even small improvements in early intervention could impact millions of patients and improve long-term outcomes.

image.png


Our Mission

Our mission is to improve early detection and prevention of viral neuroinvasion by combining predictive analytics with targeted intervention. By identifying risk sooner and responding at critical stages, we aim to protect the brain and improve outcomes for millions of patients worldwide.

bottom of page